Niceritrol: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
No edit summary
Line 24: Line 24:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
{{CMG}}
{{CMG}} {{AE}}{{SS}}
 
 
 
 
 


==Overview==
==Overview==
Line 37: Line 32:
{{Lipid modifying agents}}
{{Lipid modifying agents}}


[[Category:Nicotinates]]
[[Category:Carboxylate esters]]
[[Category:Carboxylate esters]]
[[Category:Pyridines]]
[[Category:Pyridines]]
[[Category: Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 15:12, 24 July 2014

Niceritrol
Clinical data
ATC code
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC29H24N4O8
Molar mass556.523 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Overview

Niceritrol is a niacin derivative used as a hypolipidemic agent.


Template:Lipid modifying agents


Template:WikiDoc Sources